Kevin M. Coveney's most recent trade in Enveric Biosciences Inc was a trade of 40,198 Common Stock done . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enveric Biosciences Inc | Kevin M. Coveney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 40,198 | 47,413 (1%) | 1% | 0 | Common Stock | |
| Enveric Biosciences Inc | Kevin M. Coveney | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 74,150 | 86,584 (2%) | 2% | 0 | Common Stock | |
| Enveric Biosciences Inc | M. Coveney Kevin | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 100,000 | 186,500 (5%) | 3% | 0 | Common Stock | |
| Enveric Biosciences Inc | M. Coveney Kevin | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 60,000 | 86,500 (2%) | 1% | 0 | Common Stock | |
| Enveric Biosciences Inc | Kevin M. Coveney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2023 | 26,500 | 26,500 (0%) | 0% | 0 | Common Stock |